Dr. de Solo is a native of Miami. He graduated with honors from Belen Jesuit High School, and then attended Tulane University in New Orleans for his undergraduate studies. He then completed his medical degree at Central Eastern University. He completed an Internal Medicine residency at Northeastern Ohio College of Medicine (NEOUCOM), again graduating with honors. He then completed a Rheumatology and Clinical Immunology fellowship program at the prestigious University of Alabama at Birmingham (UAB) where he actively participated in the initial clinical trials that led to the international approval of etanercept (Enbrel) for the treatment of rheumatoid arthritis. It was while at UAB, under the direction of world-renowned rheumatologists, that Dr. de Solo fined tuned the clinical, diagnostic, and procedural skills he is known for today.
He is currently an Assistant Professor of Medicine at the Florida International University (FIU) Herbert Wertheim College of Medicine (HWCOM), and has been appointed the chief of Rheumatology. He has personally mentored countless third and fourth year medical students, as well as Internal Medicine and Family Practice residents.
He also had the honor of serving on the National Board of the Arthritis Foundation, where he actively participated in establishing national policies for the benefit of patients and their access to treatment. He has also participated in advocacy on Capitol Hill by personally visiting and speaking with senators and representatives on issues related to healthcare reform.
He is also a consultant and speaker for the pharmaceutical industry where he has lectured nationally and internationally.
Dr. de Solo is bilingual, being fluent in English and Spanish. He is married and enjoys his free time with his family (including dogs and horses), and spending time at his lake house in South Carolina.